Weikang Pharmaceutical (300878.SZ) announced that on May 27, 2024, the company and relevant responsible personnel received the “Decision on Measures to Issue Warning Letters to Zhejiang Weikang Pharmaceutical Co., Ltd.” (“Warning Letter”) issued by the Zhejiang Regulatory Bureau (“Zhejiang Securities Regulatory Bureau”) of the China Securities Regulatory Commission (“Zhejiang Securities Regulatory Bureau”).
维康药业(300878.SZ)及相关人员收到浙江证监局警示函
Weikang Pharmaceutical (300878.SZ) and related personnel received a warning letter from Zhejiang Securities Regulatory Bureau
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.